China News Service, Guangzhou, June 28 (Cai Minjie, Zhang Yang) Sun Yat-sen Memorial Hospital of Sun Yat-sen University is known as the earliest western hospital in China. Nature Publishing Group recently released the latest data of the "Natural Index" of global medical institutions from 2019 to 2020 (statistics from May 1, 2019 to April 30, 2020), Sun Yat-sen Memorial Hospital of Sun Yat-sen University jumped to the 83rd in the global medical institutions Name, entered the top 100 research hospitals in the world.

  Research hospitals are guided by clinical needs, carry out cutting-edge scientific and technological research, produce high-level scientific research results and give back to clinical, so as to improve the quality and efficiency of medical services.

  Starting in 2016, the "Natural Index" ranks global research hospitals for the output of scientific and technological achievements at the forefront of medicine.

"China's earliest western hospital" has become one of the top 100 research hospitals in the world, courtesy of Zhang Yang

  In the first half of 2020, four important research results of Sun Yat-sen Memorial Hospital of Sun Yat-sen University were published in top international academic journals, ranking first in the number of hospitals in the province. Among them, Song Erwei, an academician of the Chinese Academy of Sciences and the dean of Sun Yat-sen Memorial Hospital of Sun Yat-sen University, published an article in Nature, which revealed for the first time that the tumor cell membrane protein CCDC25 as a NET-DNA receptor mediates tumor metastasis, and provides a new treatment strategy for preventing malignant tumor metastasis.

  In addition, based on a large amount of clinical CT data, the team of Professor Lin Tianxin developed a new platform for rapid diagnosis and prognosis prediction of coronavirus pneumonia to help fight against epidemics. His research results were published in "Cell"; Professor Su Shicheng's team revealed the complement for the first time Regulate the two-way mechanism of tumor B cells, provide markers for judging chemotherapy-induced anti-tumor immunity and the prognosis of patients' efficacy. The research results are published in "Cell"; Professor Huang Bingpei's team first explained the tumor in an article published in "Cell" The new function of perivascular cells in the microenvironment directly regulating tumor growth provides new targets for cancer treatment.

  The ranking of the Nature Index is calculated until April 30, 2020. (Finish)